• Info
  • Insider Trading

Steven Prestrelski - Insider Trading & Ownership

Location
C/O Xeris Pharmaceuticals, 180 N. Lasalle Street, Suite 1800, Chicago, IL
Summary
The estimated net worth of Steven Prestrelski is at least $1.35M dollars as of February 1, 2023. Steven Prestrelski is the Chief Scientific Officer of Xeris Biopharma Holdings, Inc. and owns shares of Xeris Biopharma Holdings, Inc. (XERS) stock worth about $1.35M.
Signature
/s/ Beth Hecht, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Steven Prestrelski files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Steven Prestrelski

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
XERS Xeris Biopharma Holdings, Inc. Chief Scientific Officer $1.35M Jan 31, 2023
XERS XERIS PHARMACEUTICALS INC Chief Scientific Officer Oct 5, 2021

Insider Transactions Reported by Steven Prestrelski:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.